SCHEMBL5589461

SCHEMBL5589461

CCCCc1ccc(OC(=O)O)c(O)c1CCl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.36
PPARA Q07869 2/20 0.36
TSHR P16473 2/20 0.36
PPARG P37231 1/20 0.36
ELANE P08246 1/20 0.36
CTSG P08311 1/20 0.36
ALOX5 P09917 1/20 0.35
PTGS2 P35354 1/20 0.35
NCEH1 Q6PIU2 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CTRC Q99895 1/20 0.34
BID P55957 1/20 0.34
BCL2L1 Q07817 1/20 0.34
MCL1 Q07820 1/20 0.34
BAK1 Q16611 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589679 0.92 TYR (0.36) TYRPPARATSHRPPARGELANE
SCHEMBL5586648 0.90 TYR (0.40) TYRPPARATSHRPPARGELANE
SCHEMBL5589610 0.89 TSHR (0.37) TYRPPARATSHRPPARGELANE
SCHEMBL5589577 0.89 TYR (0.38) TYRPPARATSHRPPARGELANE
SCHEMBL5590253 0.89 CYP1A2 (0.40) TYRPPARATSHRPPARGELANE
SCHEMBL5677872 0.87 TYR (0.44) TYRPPARATSHRPPARGALOX5
SCHEMBL5195274 0.87 TYR (0.44) TYRPPARATSHRPPARGALOX5
SCHEMBL5587637 0.87 AKT1 (0.34) TSHRNCEH1MEN1CYP1A2MAPT
SCHEMBL5588176 0.86 TYR (0.45) TYRPPARATSHRPPARGALOX5
SCHEMBL5676413 0.86 PRKCI (0.39) TYRPPARATSHRPPARGALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 TYR 1073/4885PPARA 2921/4885TSHR 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.